Post-remission MRD kinetics in children with acute lymphoblastic leukaemia receiving augmented BFM consolidation compared with other regimens: update of results of the Medical Research Council Trial UKALL2003

Dades bibliogràfiques
Autors principals:	Cutting, R, Richards, S, Hancock, J, Goulden, N, Mitchell, C, Vora, A
Format:	Conference item
Publicat:	2009

Post-Remission MRD Kinetics in Children with Acute Lymphoblastic Leukaemia Receiving Augmented BFM Consolidation Compared with Other Regimens Results of the Medical Research Council Trial UKALL2003.
per: Cutting, R, et al.
Publicat: (2008)

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
per: Vora, A, et al.
Publicat: (2008)

Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
per: Vora, A, et al.
Publicat: (2008)

PROSPECTIVE EVALUATION OF QUALITY OF LIFE (QOL) IN CHILDREN TREATED IN UKALL 2003 FOR ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL): A COHORT STUDY
per: Eiser, C, et al.
Publicat: (2012)

UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia
per: Vora, A, et al.
Publicat: (2010)

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
per: Vora, A, et al.
Publicat: (2013)

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
per: Vora, A, et al.
Publicat: (2013)

Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003
per: Samarasinghe, S, et al.
Publicat: (2013)

Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
per: Samarasinghe, S, et al.
Publicat: (2013)

Prospective evaluation of quality of life in children treated in UKALL 2003 for Acute Lymphoblastic Leukaemia (ALL): A cohort study
per: Eiser, C, et al.
Publicat: (2017)

Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003
per: Patrick, K, et al.
Publicat: (2014)

Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
per: Patrick, K, et al.
Publicat: (2014)

Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
per: Wheeler, K, et al.
Publicat: (1996)

Genotype-specific MRD interpretation improves stratification in paediatric acute lymphoblastic leukaemia
per: O'Connor, D, et al.
Publicat: (2017)

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
per: Vora, A, et al.
Publicat: (2014)

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial
per: Vora, A, et al.
Publicat: (2014)

Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
per: Durrant, I, et al.
Publicat: (1993)

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
per: Chessels, J, et al.
Publicat: (1997)

Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MRD) clearance in childhood acute lymphoblastic leukaemia (ALL)
per: Moorman, A, et al.
Publicat: (2007)

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
per: Chessells, J, et al.
Publicat: (1992)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1997)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1994)

Down Syndrome is a significant risk factor for infectious deaths in childhood acute lymphoblastic leukaemia: a retrospective analysis of the infectious deaths on UKALL 2003
per: O'Connor, D, et al.
Publicat: (2014)

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1995)

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
per: Chessells, J, et al.
Publicat: (1986)

Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
per: Chessells, J, et al.
Publicat: (2002)

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults.
per: Durrant, I, et al.
Publicat: (1997)

Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003.
per: O'Connor, D, et al.
Publicat: (2014)

Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe.
per: Qureshi, A, et al.
Publicat: (2010)

Outcome of Thrombosis in UKALL 2003-Anticoagulation and Re-Exposure to Aspariginase Is Feasible and Safe.
per: Qureshi, A, et al.
Publicat: (2008)

Incidence and Outcome of Osteonecrosis in Children and Young Adults with Acute Lymphoblastic Leukaemia Treated on a Dexamethasone Containing Protocol: Results of the Medical Research Council UK Trial ALL 2003
per: Vora, A, et al.
Publicat: (2008)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
per: Wheeler, K, et al.
Publicat: (1998)

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
per: Jenkinson, S, et al.
Publicat: (2013)

UKALL 2003, A Randomised Trial Investigating Treatment Intensification for Children and Young Adults with Minimal Residual Disease Defined High Risk Acute Lymphoblastic Leukaema
per: Vora, A, et al.
Publicat: (2012)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
per: Chessells, J, et al.
Publicat: (1995)

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
per: Eden, O, et al.
Publicat: (1991)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
per: Hann, I, et al.
Publicat: (2000)

Variables affecting kinetics of minimal residual disease clearance in children with lymphoblastic leukaemia; Results of the United Kingdom Medical Research Council (UK MRC) protocols ALL97, ALL97/99 and ALL2003.
per: Vora, A, et al.
Publicat: (2005)

Post-remission MRD kinetics in children with acute lymphoblastic leukaemia receiving augmented BFM consolidation compared with other regimens: update of results of the Medical Research Council Trial UKALL2003

Ítems similars

Ítems similars